Benoit Mulsant

Administrative Assistant: Rachel Delaney, rachel.delaney@utoronto.ca

Research Synopsis

The overarching goal of Dr. Mulsant’s work over the past 30+ years has been to improve the treatment of persons with severe mental disorders. His main scientific focus has been on designing and conducting complex clinical trials for “hard–to-treat” mood disorders (e.g., treatment-resistant depression, psychotic depression, bipolar disorder, late-life depression). Another major focus has been using these clinical trials as platforms to identify biomarkers or other predictors of clinical trajectories and treatment outcomes. Dr. Mulsant has been an investigator on grants with funding totaling more than $180M in direct costs (including $73M as principal investigator or team leader, and $32M as a co-principal investigator). He has authored and co-authored more than 670 peer-reviewed articles (and 65 book chapters and invited publications). His publications (including some in the New England Journal of Medicine, Lancet, and JAMA) have resulted in more than 50,000 citations and an h-index of 110.